Triangle Business Journal by Lauren K. Ohnesorge, Staff Writer
Hillsborough-based InnerOptic has netted FDA approval for its AIM System, a biopsy system for guiding a needle and predicting its path on a monitor.
Called “GPS for needle-based interventions,” the technology provides 3D visualization for ultrasound-assisted surgeries including both biopsies and ablations.
To date, AIM has been integrated with ultrasound scanners from BK Medical and Aloka as well as devices from both Halt Medical and Microsulis.
The research was funded, in part, by a National Institutes of Health grant. InnerOptic Technology was founded by UNC-Chapel Hill researchers in 2003.
